secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001140361-24-048475
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma GM Commercial Affairs Mark White resigns effective Jan 1
----------------------------------------------------------------------

- Mark White resigns as General Manager, Commercial Affairs, effective January 1, 2025.
- No successor has been named.
- The company did not disclose a reason for the resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124048475/0001140361-24-048475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124048475/ef20039631_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-048475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer